Trials / Completed
CompletedNCT06262256
Effects of High-intensity Interval Training on Myocardial Strain in Metabolic Syndrome Patients
Effects of High-intensity Interval Training on Myocardial Strain in Patients With Metabolic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- University of Castilla-La Mancha · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
the effects of high-intensity interval training on myocardial function will be studied in a group of patients under medical treatment for the components of metabolic syndrome.
Detailed description
Objective: To analyze the effects of high-intensity interval training (HIIT) on myocardial function of metabolic syndrome patients. Methods and design. Randomized clinical trial with a control group. Project was developed in association with the regional general hospital. Pre and post-intervention evaluation after 16 weeks of training for the HIIT group. Subjects: Recruited using adverts published on public medical center boards. Up to 30 subjects per group (HIIT and CONTROL) will be recruited (at least 20% women) Measurements. Echocardiography: Global longitudinal strain (GLS), Mitral filling parameters, myocardial dimensions, and myocardial wall thickness. Cardiorespiratory fitness: Maximal oxygen consumption, Maximal power output, Maximal oxygen pulse. Clinical: Metabolic syndrome components and derived variables (e.g., triglycerides/high-density lipoprotein ratio) Body composition by anthropometric measurements and dual-energy X-ray absorptiometry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | High-intensity interval training | supervised exercise conducted on stationary bikes after individualized intensity prescription. |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2023-05-30
- Completion
- 2023-12-22
- First posted
- 2024-02-15
- Last updated
- 2024-02-15
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06262256. Inclusion in this directory is not an endorsement.